SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ARIAD Pharmaceuticals
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
4474 134 0 ARIA
Emcee:  jaybe Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4199Vid, I couldn't agree more and appreciate your level headed, objective approflexinvesting-4/22/2016
4198So at this point we are over 70 percent higher than the 52 week low while the biVidpok1-4/21/2016
4197RSI is trading near to 65.33 level with positive bias, MACD and Signal line is shollyhunter-4/20/2016
4196ASCO presentation titles available online... Three presentations for briga, onljaybe-4/20/2016
4195Jess, I think you are correct, the implication of that statement is that Brig Vidpok1-4/15/2016
4194Yes, that 100% results look GOOD. <g> Phase 1/2 trial of Jibacoa-4/15/2016
4193Vid, what resonates most in the release I think is the 100% one year survival rajesspro-4/15/2016
4192looks like brig is starting to fulfill the promise which was apparent from the eVidpok1-4/15/2016
4191Briga's ALTA 1L trial listed on clinicaltrials.gov... Estimated Primary Comjaybe-4/14/2016
4190Correction...'788 cannot be a late-breaker at ASCO, since only Phase 2 or 3 jaybe-4/14/2016
4189The patent only generally describes potency, as in IC50s below 100nM get an 'jaybe-4/13/2016
4188Canadian assessment of cost-effectiveness of pona in 3L CML... slideshare.netjaybe-4/13/2016
4187Thanks. That is exactly what I am looking for. I am a bit surprised, though. GregorioAllegri-4/13/2016
4186Definitely a real opportunity, and the patent does identify the indication, howejaybe-4/12/2016
4185Good to see you back and I agree 100% brigatinib is the big driver now. Any thoutestad-4/12/2016
4184There was a paper out of Roche linked here some time back that demonstrated thatBiomaven-4/12/2016
4183Have bought back about half my former horde at about 25 cents less than I sold iGregorioAllegri-4/12/2016
4182Gregorio Allegri, wow have not seen your name associated with ARIA in a long timtestad-4/12/2016
4181Any thoughts on the potential of AP32788 in breast cancer? HER2+ breast cancer GregorioAllegri-4/12/2016
4180Pona potential in crizotinib-resistant ROS1 NSCLC... "The drug ponatinib, jaybe-4/11/2016
4179German drug agency issues "red-hand letter" to all Bcr-Abl TKIs regardjaybe-4/10/2016
4178<i>If Ariad is smart...</i> An object of daily discussion on the iHtom pope-4/8/2016
4177If Ariad is smart, they will try to incorporate liquid biopsies into all their tBiomaven-4/8/2016
4176Swedish study lays groundwork for briga in neuroblastoma... "In summary, wjaybe14/2/2016
4175For those interested...recent overview of targeted therapy for NSCLC... handoutjaybe23/30/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News